Systematic Infection of Chlamydia Pneumoniae

Clinical Laboratory
|August 17, 2022
PubMed
Abstract

Insights

Chlamydia pneumoniae (Cpn) infection can spread systematically, contributing to chronic diseases like atherosclerosis and Alzheimer's. This review explores Cpn's mechanisms, immune responses, and links to extrapulmonary conditions.

Area of Science:

  • Microbiology
  • Immunology
  • Pathology

Background:

  • Chlamydia pneumoniae (Cpn) is a common respiratory pathogen and obligate intracellular parasite.
  • Cpn infection can disseminate systemically via blood transmission, involving monocytes, lymphocytes, and macrophages.
  • This dissemination can lead to extrapulmonary symptoms and chronic conditions.

Purpose of the Study:

  • To review the mechanisms of Cpn infection in host cells.
  • To summarize the host immune response to Cpn infection.
  • To explore the association between Cpn infection and chronic diseases.

Main Methods:

  • Literature review of Cpn infection mechanisms.
  • Analysis of immune responses to Cpn.
  • Examination of Cpn's role in chronic disease development.

Main Results:

  • Cpn DNA has been detected in atherosclerotic (AS) plaque, nerve tissues, and joint synovium.
  • Evidence supports Cpn's involvement in extrapulmonary chronic diseases.
  • Cpn infection is linked to systemic manifestations.

Conclusions:

  • Cpn infection is implicated in the pathogenesis of chronic diseases, including atherosclerosis, Alzheimer's Disease (AD), and reactive arthritis.
  • Both in vivo and in vitro studies support the link between Cpn and chronic disease development.
  • Understanding Cpn's role is crucial for managing these conditions.

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
84
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
314
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
457
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
415
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
404
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
435